MedTrace Logo

A Multimodal Analgesia Protocol Adapted for Ambulatory Surgery

NCT04015908 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-07-08

Study results available
· View outcomes & findings →

Summary

The primary objective of this trial is to determine whether the combination of three non-opioid analgesics (multimodal analgesia) can significantly reduce or eliminate the need for opioids after ambulatory surgery.

A secondary objective would be to present credible data for insurance providers about the opioid sparing effect of these medications. This data may encourage insurance providers to support payment for short term use of certain analgesics that currently require prior authorization.

Conditions

  • Opioid Use

Interventions

DRUG

Celecoxib

Celecoxib 100mg

DRUG

Acetaminophen

Acetaminophen 325mg

DRUG

Pregabalin

Pregabalin 50 mg

DRUG

Oxycodone

oxycodone 5-10 mg

DRUG

Percocet

Percocet (oxycodone 5mg/acetaminophen 325 mg)

Sponsors & Collaborators

Principal Investigators

  • Jeffrey Swenson, MS · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2023-01-31
Completion
2023-01-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04015908 on ClinicalTrials.gov